Connect your AI

LanzaTech Global, Inc. LNZA AFS Securities

AFS Securities at other companies

KBRKBR

$49M—

Ligand PharmaceuticalsLGND

$237M+4,934%

Other financials

Income statement

Revenue$12.0M+26.8%

Operating income-$9.8M+68.4%

Net income-$14.7M+23.7%

EPS (diluted)-$1.77+81.9%

Balance sheet

Cash & equivalents$19.9M+23.9%

Total debt$16.3M-46.1%

Total equity$48.1M+4,194%

Total assets$105.2M-16.4%

Cash flow

Operating cash flow-$9.3M+56.1%

CapEx$55.0K-92.3%

Free cash flow-$9.3M+57.3%

Valuation

Market cap$75.63M-75.8%

Enterprise value$72.09M-75.1%

P/S1.3×-6.4×

Profitability

Operating margin-99.2%-36.2pp

Net margin-76.1%-31.8pp

FCF margin-91.8%-29.8pp

Returns & leverage

Return on equity-215.3%—

Debt / equity0.3×—

Current ratio2×-0.2×

Where this comes from

Reported directly by LanzaTech Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue.

The official record: LanzaTech Global, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about LanzaTech Global, Inc.'s afs securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LanzaTech Global, Inc.'s AFS securities?: LanzaTech Global, Inc. (LNZA) reported AFS securities of $14.99M in Q1 2026.
How has LanzaTech Global, Inc.'s AFS securities changed year-over-year?: LanzaTech Global, Inc.'s AFS securities decreased by 0.0% year-over-year, from $14.99M to $14.99M.
What is the long-term trend for LanzaTech Global, Inc.'s AFS securities?: Over 3 years (2022 to 2025), LanzaTech Global, Inc.'s AFS securities has grown at a 0.0% compound annual growth rate (CAGR), from $14.99M to $14.99M.
What does AFS securities mean?: Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.